
About Us
Our Mission
The Future of Medicine Is Not One-Size-Fits-All.
Neo7Bioscience exists to uncover what conventional answers may miss—using each patient's biology to guide a truly individualized therapeutic strategy.
We are working to transform how life-threatening, chronic, and complex conditions are understood and addressed—not only for patients today, but for generations to come.
Through advanced molecular science, bold innovation, and unwavering legal and ethical standards, we are building a future where treatment begins with the individual.
One patient. One biology. A new possibility.


Our Vision
We envision a future where healthcare is no longer reactive, but predictive, preventive, and precisely tailored to every individual.
Through cutting-edge molecular design and aHI-driven strategies, we aim to redefine how diseases are understood and treated.
Visionary Leaders Driving
Precision Medicine Forward
Meet the pioneering experts behind Neo7Bioscience's groundbreaking innovations in molecular therapeutics and aHI-driven healthcare solutions.

Dr. John A. Catanzaro
Dr. John A. Catanzaro is a pioneering leader in precision molecular medicine, specializing in personalized peptide engineering, OMICS-driven bioinformatics therapeutics, and signal-based molecular interventions. He earned his Doctorate of Naturopathic Medicine (NMD) from Bastyr University in 1995 and a Doctorate of Theology in Science and Medical Ethics (PhD) from Bethany Divinity Seminary in 2012.
With over two decades of expertise in precision and integrative medicine, Dr. Catanzaro has spearheaded advancements in high-definition molecular surveillance and immunomolecular augmentation, developing groundbreaking personalized peptide solutions for complex disease states. He is the co-inventor of an augmented Hybrid Intelligence (aHI) system, an advanced platform that seamlessly integrates human intelligence, knowledge-based applications, and Artificial Super Intelligence (ASI). This innovation powers the Precision-Based Immunomolecular Augmentation (PBIMA) platform—a revolutionary approach that optimizes cellular function through patient-specific molecular data.
A relentless advocate for next-generation patient-specific therapeutics, Dr. Catanzaro’s work bridges the frontier of cutting-edge science and transformative clinical applications, shaping the future of precision medicine through intelligent molecular signaling and redefining personalized healthcare

Stuart Ross
Stuart Ross received a Bachelor of Science in Business Administration from City University in 1988 and is a Certified Project Management Professional. He has 30 years of leadership experience within the U.S. Air Force, software development, banking, travel, business management, data center, and aerospace manufacturing/engineering environments. He has vast experience providing high caliber business and project management support in large, cross-functional and cross organizational IT production infrastructure environments. Proficient at communicating with senior management, leadership, IT personnel, customers, and vendors. Highly skilled at resource allocation, progress tracking, change control and business processes, testing, risk analysis, release management, training, and on-time delivery within budget constraints. He has successfully managed thousands of stakeholders, team members, and vendors during the completion of hundreds of complex IT infrastructure and business process-based projects.

Monica Satterwhite
Monica Satterwhite brings nearly 30 years of experience in functional health, clinical case and practice management, patient education, and complex disease support. Throughout her career, Monica has designed and managed corporate wellness programs for international technology, aviation, and development organizations, as well as financial and educational institutions. She has also conducted published research in corporate health and developed a cancer-focused health application.
Monica earned a Bachelor of Science in Nutritional Science from Texas A&M University in 1994 and a Master of Science in Health Promotion from University of North Texas in 2001. At Neo7Bioscience, Monica works with physicians and clinical teams to translate advanced molecular technology into understandable, clinically relevant strategies. Her work focuses on expanding provider capacity, strengthening the quality of personalized care, and creating opportunities for practice growth and improved patient support.
Monica believes advanced personalized care should not be reserved for a select few. Her mission is to make complex science understandable, actionable, and accessible—so more providers can offer every patient care designed around their individual biology.
Our Science and Molecular Development Team
Meet the pioneering researchers, bioinformaticians, and molecular scientists leading our computational pipelines and individualized therapeutic designs.
Anton Yuryev
Specializing in molecular biology, drug development, bioinformatics, NLP, aHI, ML, and knowledge-based engineering biological database development at Elsevier.

Igor Fesenko
Dedicated researcher in molecular analytics, microproteins, peptides, proteomics, molecular biology, bioinformatics, and data analysis and visualization.

Philipp Anokhin
NLP, aHI, algorithm engineering, biological surveillance and prediction, bioinformatics, cloud-based engineering, and software development.

Dhaval Patel
aHI and NGS Data sequencing, Software requirement analysis, Software system architecture, database design and development and bioinformatics tools.

Wei Zhang
Molecular biology, bioinformatics, cancer and disease signaling, genomics, machine learning.

Natalia Von Ranke
Protein modeling, bioinformatics, molecular simulation, pharmacy, drug discovery, and development.

Elisa Pereira
Genomics, bioinformatics, molecular epidemiology, genomic surveillance, infectious diseases, and NGS analysis.
Marketing Team
Shaping how the science and vision of precision medicine are communicated to modern audiences through elevated storytelling and digital experiences.
Deanna Davis
Digital media strategy, digital marketing, content creation, brand storytelling, and digital brand management.
Deanna leads digital content and social media initiatives at Neo7Bioscience, translating precision medicine into compelling digital experiences that strengthen brand identity and engagement.
Clinical & Educational Services Team
Dr. Robinson and Dr. Morales will be providing clinical and educational consulting services for Neo7Bioscience, focusing on precision medicine cellular & molecular biology, immunology, and evidence-based health sciences.

Dr. Michael Robinson
Physician, Professor, and Nutrition Expert specializing in functional medicine, autoimmunity, and integrative oncology. Owner of Nourish Healthcare LLC, Staff Doctor in Oncology at Ayre Clinic, and DCN Teaching Faculty at University of Western States. Focusing on precision medicine cellular & molecular biology, immunology, and evidence-based health sciences.

Dr. Jorge Luis Morales Cardona
Naturopathic Doctor, Certified Nutrition Specialist, and M.A. Candidate in Molecular Medicine (Liberty University School of Medicine). Clinical Resident in Integrative Oncology & Advanced Therapeutics, focusing on precision medicine cellular & molecular biology, immunology, and evidence-based health sciences.
Industry Partners
Neo7Bioscience partners with labs, manufacturers and other suppliers to advance and deliver molecular technologies.
Email partner@neo7bioscience.com with your company information and area of interest for partnership opportunities
